v3.25.4
Collateralized Transactions
12 Months Ended
Dec. 31, 2025
Collateralized Agreements [Abstract]  
Collateralized Transactions Collateralized Transactions
The Firm enters into securities purchased under agreements to resell, securities sold under agreements to repurchase, securities borrowed and securities loaned transactions to, among other things, acquire securities to cover short positions and settle other securities obligations, to accommodate customers’ needs and to finance its inventory positions.
The Firm monitors the fair value of the underlying securities as compared with the related receivable or payable, including accrued interest, and, as necessary, requests additional collateral, as provided under the applicable agreement to ensure such transactions are adequately collateralized, or returns excess collateral.
The risk related to a decline in the market value of collateral pledged or received is managed by setting appropriate market-based margin requirements. Increases in collateral margin calls on secured financing due to market value declines may be mitigated by increases in collateral margin calls on securities purchased under agreements to resell and securities borrowed transactions with similar quality collateral. Additionally, the Firm may request lower quality collateral pledged be replaced with higher quality collateral through collateral substitution rights in the underlying agreements.
The Firm actively manages its secured financings in a manner that reduces the potential refinancing risk of secured financings of less liquid assets and also considers the quality of collateral when negotiating collateral eligibility with counterparties. The Firm utilizes shorter term secured financing for highly liquid assets and has established longer tenor limits for less liquid assets, for which funding may be at risk in the event of a market disruption.
Offsetting of Certain Collateralized Transactions
 At December 31, 2025
$ in millionsGross
Amounts
Amounts
Offset
Balance Sheet Net Amounts
Amounts
Not Offset1
Net
Amounts
Assets
Securities purchased under agreements to resell$471,144 $(350,901)$120,243 $(117,509)$2,734 
Securities borrowed218,753 (66,845)151,908 (146,726)5,182 
Liabilities
Securities sold under agreements to repurchase$429,440 $(350,901)$78,539 $(72,407)$6,132 
Securities loaned84,155 (66,845)17,310 (17,213)97 
Amounts for which master netting agreements are not in place or may not be legally enforceable, included in Net Amounts
Securities purchased under agreements to resell$1,277 
Securities borrowed38 
Securities sold under agreements to repurchase5,367 
 At December 31, 2024
$ in millionsGross
Amounts
Amounts
Offset
Balance Sheet Net Amounts
Amounts
Not Offset1
Net
Amounts
Assets
Securities purchased under agreements to resell$409,635 $(291,070)$118,565 $(116,157)$2,408 
Securities borrowed165,642 (41,783)123,859 (117,573)6,286 
Liabilities
Securities sold under agreements to repurchase$341,137 $(291,070)$50,067 $(45,520)$4,547 
Securities loaned57,009 (41,783)15,226 (15,211)15 
Amounts for which master netting agreements are not in place or may not be legally enforceable, included in Net Amounts
Securities purchased under agreements to resell$2,054 
Securities borrowed2,079 
Securities sold under agreements to repurchase3,448 
1.Amounts relate to master netting agreements that have been determined by the Firm to be legally enforceable in the event of default but where certain other criteria are not met in accordance with applicable offsetting accounting guidance.
For information related to offsetting of derivatives, see Note 6.
Gross Secured Financing Balances by Remaining Contractual Maturity
 At December 31, 2025
$ in millionsOvernight and OpenLess than 30 Days30-90 DaysOver 90 DaysTotal
Securities sold under agreements to repurchase$221,938 $122,291 $43,737 $41,474 $429,440 
Securities loaned70,433  321 13,401 84,155 
Total included in the offsetting disclosure$292,371 $122,291 $44,058 $54,875 $513,595 
Trading liabilities—Obligation to return securities received as collateral7,329    7,329 
Total$299,700 $122,291 $44,058 $54,875 $520,924 
 At December 31, 2024
$ in millionsOvernight and OpenLess than 30 Days30-90 DaysOver 90 DaysTotal
Securities sold under agreements to repurchase$180,793 $104,551 $25,071 $30,722 $341,137 
Securities loaned42,473 — 317 14,219 57,009 
Total included in the offsetting disclosure$223,266 $104,551 $25,388 $44,941 $398,146 
Trading liabilities—Obligation to return securities received as collateral18,067 — — — 18,067 
Total$241,333 $104,551 $25,388 $44,941 $416,213 
Gross Secured Financing Balances by Class of Collateral Pledged
$ in millions
At
December 31, 2025
At
December 31, 2024
Securities sold under agreements to repurchase
U.S. Treasury and agency securities$209,470 $177,464 
Other sovereign government obligations159,444 135,806 
Corporate equities32,919 14,993 
Other27,607 12,874 
Total$429,440 $341,137 
Securities loaned
Other sovereign government obligations$1,208 $1,805 
Corporate equities81,063 54,144 
Other1,884 1,060 
Total$84,155 $57,009 
Total included in the offsetting disclosure$513,595 $398,146 
Trading liabilities—Obligation to return securities received as collateral
Corporate equities$7,017 $18,059 
Other312 
Total$7,329 $18,067 
Total$520,924 $416,213 
Carrying Value of Assets Loaned or Pledged without Counterparty Right to Sell or Repledge
$ in millions
At
December 31, 2025
At
December 31, 2024
Trading assets$43,182 $30,867 
The Firm pledges certain of its trading assets to collateralize securities sold under agreements to repurchase, securities loaned, other secured financings and derivatives and to cover customer short sales.
Pledged financial instruments that can be sold or repledged by the secured party are identified as Trading assets (pledged as collateral) in the balance sheet. Pledged financial instruments that cannot be sold or repledged by the secured party are included within Trading Assets, but not identified as pledged assets parenthetically in the balance sheet.
Fair Value of Collateral Received with Right to Sell or Repledge
$ in millions
At
December 31, 2025
At
December 31, 2024
Collateral received with right to sell or repledge$1,190,694 $932,626 
Collateral that was sold or repledged1
900,282 724,177 
1.Does not include securities used to meet federal regulations for the Firm’s U.S. broker-dealers.
The Firm receives collateral in the form of securities in connection with securities purchased under agreements to resell, securities borrowed, securities-for-securities transactions, derivative transactions, customer margin loans and securities-based lending. In many cases, the Firm is permitted to sell or repledge this collateral to secure securities sold under agreements to repurchase, to enter into securities lending and derivative transactions or to deliver to counterparties to cover short positions.
Securities Segregated for Regulatory Purposes
$ in millions
At
December 31, 2025
At
December 31, 2024
Segregated securities1
$22,256 $26,329 
1.Securities segregated under federal regulations for the Firm’s U.S. broker-dealers are sourced from Securities purchased under agreements to resell and Trading assets in the balance sheet.
Concentration Based on the Firm’s Total Assets
At
December 31, 2025
At
December 31, 2024
U.S. government and agency securities and other sovereign government obligations
Trading assets1
12 %11 %
Off balance sheet—Collateral received2
9 %12 %
1.Other sovereign government obligations included in Trading assets primarily consist of obligations of the U.K., Japan and Brazil.
2.Collateral received is primarily related to Securities purchased under agreements to resell and Securities borrowed.
The Firm is subject to concentration risk by holding large positions in certain types of securities, loans or commitments to purchase securities of a single issuer, including sovereign governments and other entities, issuers located in a particular country or geographic area, public and private issuers involving developing countries or issuers engaged in a particular industry.
Positions taken and underwriting and financing commitments, including those made in connection with the Firm’s private equity, principal investment and lending activities, often involve substantial amounts and significant exposure to individual issuers and businesses, including investment grade and non-investment grade issuers.
Customer Margin and Other Lending
$ in millions
At
December 31, 2025
At
December 31, 2024
Margin and other lending$83,871 $55,882 
The Firm provides margin lending arrangements that allow customers to borrow against the value of qualifying securities. Receivables from these arrangements are included within Customer and other receivables in the balance sheet. Under these arrangements, the Firm receives collateral, which includes U.S. government and agency securities, other sovereign government obligations, corporate and other debt, and corporate equities. Margin loans are collateralized by customer-owned securities held by the Firm. The Firm monitors required margin levels and established credit terms daily and, pursuant to such guidelines, requires customers to deposit additional collateral, or reduce positions, when necessary.
Margin loans are extended on a demand basis and generally are not committed facilities. Factors considered in the review of margin loans are the amount of the loan, the intended purpose, the degree of leverage being employed in the account and the amount of collateral, as well as an overall evaluation of the portfolio to ensure proper diversification or, in the case of concentrated positions, appropriate liquidity of the underlying collateral or potential hedging strategies to reduce risk. Underlying collateral for margin loans is reviewed with respect to the liquidity of the proposed collateral positions, valuation of securities, historic trading range, volatility analysis and an evaluation of industry concentrations. For these transactions, adherence to the Firm’s collateral policies significantly limits its credit exposure in the event of a customer default. The Firm may request additional margin collateral from customers, if appropriate, and, if necessary, may sell securities that have not been paid for or purchase securities sold but not delivered from customers.
Also included in the amounts in the previous table is non-purpose securities-based lending on entities in the Wealth Management business segment.
Other Secured Financings
Other secured financings include the liabilities related to collateralized notes, transfers of financial assets that are accounted for as financings rather than sales and consolidated VIEs where the Firm is deemed to be the primary beneficiary. These liabilities are generally payable from the cash flows of the related assets accounted for as Trading assets (see Notes 13 and 15). Additionally, for certain secured financing transactions that meet applicable netting criteria, the Firm offset Other secured financing liabilities against financing receivables recorded within Trading assets in the amount of $3,410 million and $437 million as of December 31, 2025 and December 31, 2024, respectively.